Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Drug Screening

Request Info
 
Facebook Twitter LinkedIn Email Comments
A label-free drug discovery technology called Soprano has been introduced by PharmaDiagnostics NV. The screening tool, which does not require special equipment, uses a technique called localized surface plasmon resonance to analyze small molecules and proteins of interest using gold nanoparticles. It uses a standard plate reader and a 96- or 384-well format to analyze enzymatic reactions, ADME/PK, or ligand receptor and protein binding.


BioPhotonics
Apr 2010
REQUEST INFO ABOUT THIS PRODUCT

* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address:
Address 2:
City:
State/Province:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required

When you click "Send Request", we will record and send your personal contact information to the supplier by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.
MORE FROM PHOTONICS MEDIA
BreakthroughProducts
surface plasmon resonance
384-well96-wellADMEBiophotonicsBreakthroughProductsdrug discoveryenzymatic reactionsgold nanoparticlelabel-freeligand receptormoleculesnanoparticlesPharmaDiagnosticsPKplate readerproteinprotein bindingscreeningSopranosurface plasmon resonance

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
X
Are you interested in this product?
When you click "Send Request", we will send the contact details you supply to so they may respond to your inquiry directly.

Email Address:
Name:
Company:
Stop showing me this for the remainder of my visit
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.